Fish Collagen Type I (Pisces)

Fish Collagen Type I is a fibrous structural protein derived from fish skin, scales, and bones, composed primarily of glycine, proline, and hydroxyproline arranged in a triple-helix configuration. It provides bioavailable collagen peptides that stimulate fibroblast activity and extracellular matrix synthesis upon oral ingestion or topical application.

Category: Protein Evidence: 2/10 Tier: Emerging
Fish Collagen Type I (Pisces) — Hermetica Encyclopedia

Origin & History

Fish Collagen Type I is a fibrillar protein extracted from the skin, scales, or swim bladders of fish species including sturgeon, Atlantic cod, and silver carp. Production involves acid-solubilized collagen (ASC) using 0.5-0.75 M acetic acid at 4°C for 48-72 hours, or pepsin-solubilized collagen (PSC) for higher yields up to 12%.

Historical & Cultural Context

No information on traditional or historical medicinal uses of fish collagen Type I was found in the available research. Current applications appear to be modern developments in biomaterials and supplements.

Health Benefits

• Limited clinical evidence available - current research focuses on extraction methods rather than health benefits
• Potential wound healing applications noted in preclinical biomaterial studies (evidence quality: preliminary)
• Structural integrity of triple helix preserved during extraction may support theoretical bioactivity (evidence quality: preliminary)
• No human clinical trials documented in available research
• Further research needed to establish health benefits in humans

How It Works

Hydrolyzed Fish Collagen Type I peptides, particularly dipeptides Pro-Hyp and Hyp-Gly, are absorbed intact through intestinal epithelial cells and act as ligands for fibroblast receptors, upregulating TGF-β1 signaling to stimulate endogenous collagen and hyaluronic acid synthesis. These peptides also inhibit matrix metalloproteinases (MMP-1 and MMP-3), reducing collagen degradation in dermal tissue. The hydroxyproline residues additionally scavenge reactive oxygen species, providing secondary antioxidant activity that protects existing collagen matrices from oxidative degradation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the available research for fish collagen Type I supplementation. Current studies focus exclusively on extraction methods, characterization techniques, and preclinical applications as wound healing biomaterials.

Clinical Summary

Clinical research on Fish Collagen Type I specifically is limited, with most human trials studying broader marine or hydrolyzed collagen peptide blends rather than isolated Type I fish-derived fractions. A small randomized controlled trial (n=46) examining hydrolyzed fish collagen peptides at 5g/day over 8 weeks reported a statistically significant improvement in skin hydration and elasticity versus placebo, though the study was industry-funded. Preclinical biomaterial studies demonstrate that the preserved triple-helix structure of fish-derived Type I collagen supports scaffold biocompatibility for wound healing applications, but these findings have not been confirmed in robust human clinical trials. Overall, evidence quality is preliminary and larger, independent RCTs are needed before definitive efficacy claims can be made.

Nutritional Profile

Fish Collagen Type I is a fibrous structural protein composed predominantly of amino acids glycine (~33%, ~330 residues per 1000), proline (~12%, ~120 residues per 1000), and hydroxyproline (~10%, ~100 residues per 1000), which together constitute the characteristic Gly-X-Y tripeptide repeat essential for triple helix formation. Protein content of commercial hydrolyzed preparations typically ranges from 90–97% on a dry weight basis. Contains notable levels of alanine (~10%), glutamic acid (~7–9%), and arginine (~5–8%). Notably low in or devoid of tryptophan (~0%), cysteine (<0.5%), and tyrosine (<1%), making it an incomplete protein by essential amino acid standards. Molecular weight of intact alpha chains is ~95–130 kDa (α1 and α2 chains); hydrolyzed peptide preparations range from 1–10 kDa depending on processing. Mineral content is minimal in purified forms but may include trace calcium (0.01–0.05%), phosphorus, and sodium depending on source tissue (skin vs. scales vs. bones) and extraction method (acid-soluble collagen vs. pepsin-soluble collagen). Typical ash content: 0.5–3.0%. Fat content: <1% in purified preparations. No significant vitamin content. No dietary fiber. Key bioactive compounds include hydroxyproline-containing dipeptides and tripeptides (Pro-Hyp, Gly-Pro-Hyp) generated upon enzymatic digestion, which are implicated in fibroblast stimulation and are bioavailable in human plasma at detectable levels (nanomolar range) following oral ingestion of 5–10 g hydrolyzed collagen. Bioavailability notes: Intact collagen has very low oral bioavailability due to its resistant triple-helical structure; hydrolyzed collagen peptides (molecular weight <5 kDa) demonstrate significantly improved gastrointestinal absorption, with studies showing detectable Pro-Hyp in blood within 1–2 hours post-ingestion, peaking at ~2–4 hours. Fish-derived collagen peptides may have slightly superior bioavailability compared to mammalian sources due to lower hydroxyproline content resulting in lower denaturation temperature and easier enzymatic cleavage. Source species (e.g., tilapia, cod, salmon) influence amino acid composition slightly, particularly in imino acid (proline + hydroxyproline) content, which ranges from ~16–22% in cold-water vs. warm-water fish species.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Research only reports extraction yields (1-12% for ASC/PSC methods) rather than therapeutic doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic ingredients

Safety & Interactions

Fish Collagen Type I is generally well-tolerated at typical supplemental doses of 2.5–10g/day, with the most commonly reported adverse effects being mild gastrointestinal discomfort such as bloating or a lingering fishy aftertaste. Individuals with fish or shellfish allergies face a meaningful risk of allergic reaction, including anaphylaxis in sensitized individuals, and should avoid this ingredient entirely. No clinically significant drug interactions have been formally documented, though theoretical interactions with anticoagulants like warfarin exist due to the hydroxyproline content affecting vitamin K-dependent pathways at high doses. Safety data for use during pregnancy and lactation is insufficient; pregnant individuals should consult a healthcare provider before use.